141 related articles for article (PubMed ID: 15369741)
1. Muscle-specific receptor tyrosine kinase autoantibodies--a new immunoprecipitation assay.
Matthews I; Chen S; Hewer R; McGrath V; Furmaniak J; Rees Smith B
Clin Chim Acta; 2004 Oct; 348(1-2):95-9. PubMed ID: 15369741
[TBL] [Abstract][Full Text] [Related]
2. A sensitive non-isotopic assay for acetylcholine receptor autoantibodies.
Hewer R; Matthews I; Chen S; McGrath V; Evans M; Roberts E; Nute S; Sanders J; Furmaniak J; Smith BR
Clin Chim Acta; 2006 Feb; 364(1-2):159-66. PubMed ID: 16051208
[TBL] [Abstract][Full Text] [Related]
3. Clinical and serological study of myasthenia gravis using both radioimmunoprecipitation and cell-based assays in a South Asian population.
Chang T; Leite MI; Senanayake S; Gunaratne PS; Gamage R; Riffsy MT; Jacobson LW; Adhikari M; Perera S; Vincent A
J Neurol Sci; 2014 Aug; 343(1-2):82-7. PubMed ID: 24929651
[TBL] [Abstract][Full Text] [Related]
4. [Autoantibodies detected in acetylcholine receptor antibody-negative myasthenia gravis].
Ohta R; Motomura M
Rinsho Byori; 2014 Mar; 62(3):255-60. PubMed ID: 24800501
[TBL] [Abstract][Full Text] [Related]
5. Anti-MuSK myasthenia gravis presenting with purely ocular findings.
Caress JB; Hunt CH; Batish SD
Arch Neurol; 2005 Jun; 62(6):1002-3. PubMed ID: 15956173
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics of MuSK antibody-positive myasthenia gravis in Taiwan.
Huang YC; Yeh JH; Chiu HC; Chen WH
J Formos Med Assoc; 2008 Jul; 107(7):572-5. PubMed ID: 18632417
[TBL] [Abstract][Full Text] [Related]
7. Development of a highly sensitive diagnostic assay for muscle-specific tyrosine kinase (MuSK) autoantibodies in myasthenia gravis.
Trakas N; Zisimopoulou P; Tzartos SJ
J Neuroimmunol; 2011 Dec; 240-241():79-86. PubMed ID: 21993075
[TBL] [Abstract][Full Text] [Related]
8. MuSK autoantibodies in myasthenia gravis detected by cell based assay--A multinational study.
Tsonis AI; Zisimopoulou P; Lazaridis K; Tzartos J; Matsigkou E; Zouvelou V; Mantegazza R; Antozzi C; Andreetta F; Evoli A; Deymeer F; Saruhan-Direskeneli G; Durmus H; Brenner T; Vaknin A; Berrih-Aknin S; Behin A; Sharshar T; De Baets M; Losen M; Martinez-Martinez P; Kleopa KA; Zamba-Papanicolaou E; Kyriakides T; Kostera-Pruszczyk A; Szczudlik P; Szyluk B; Lavrnic D; Basta I; Peric S; Tallaksen C; Maniaol A; Casasnovas Pons C; Pitha J; Jakubíkova M; Hanisch F; Tzartos SJ
J Neuroimmunol; 2015 Jul; 284():10-7. PubMed ID: 26025053
[TBL] [Abstract][Full Text] [Related]
9. Flow Cytofluorimetric Analysis of Anti-LRP4 (LDL Receptor-Related Protein 4) Autoantibodies in Italian Patients with Myasthenia Gravis.
Marino M; Scuderi F; Samengo D; Saltelli G; Maiuri MT; Shen C; Mei L; Sabatelli M; Pani G; Antonini G; Evoli A; Bartoccioni E
PLoS One; 2015; 10(8):e0135378. PubMed ID: 26284792
[TBL] [Abstract][Full Text] [Related]
10. Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients.
Zhou L; McConville J; Chaudhry V; Adams RN; Skolasky RL; Vincent A; Drachman DB
Muscle Nerve; 2004 Jul; 30(1):55-60. PubMed ID: 15221879
[TBL] [Abstract][Full Text] [Related]
11. Non-radioactive serological diagnosis of myasthenia gravis and clinical features of patients from Tianjin, China.
Yang L; Maxwell S; Leite MI; Waters P; Clover L; Fan X; Zhang D; Yang C; Beeson D; Vincent A
J Neurol Sci; 2011 Feb; 301(1-2):71-6. PubMed ID: 21131008
[TBL] [Abstract][Full Text] [Related]
12. Age at sampling and sex distribution of AChRAb vs. MuSKAb myasthenia gravis in a large Greek population.
Belimezi M; Kalliaropoulos A; Jiménez J; Garcia I; Mentis AA; Chrousos GP
Clin Neurol Neurosurg; 2021 Sep; 208():106847. PubMed ID: 34343914
[TBL] [Abstract][Full Text] [Related]
13. Muscle-specific receptor tyrosine kinase antibody-positive and seronegative myasthenia gravis.
Muppidi S; Wolfe GI
Front Neurol Neurosci; 2009; 26():109-119. PubMed ID: 19349708
[TBL] [Abstract][Full Text] [Related]
14. [Clinical features of myasthenia related with autoantibodies to muscle specific tyrosine kinase (MuSK)].
Sanadze AG; Sidnev DV; Karganov MIu
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):72-6. PubMed ID: 21311492
[TBL] [Abstract][Full Text] [Related]
15. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
Hoch W; McConville J; Helms S; Newsom-Davis J; Melms A; Vincent A
Nat Med; 2001 Mar; 7(3):365-8. PubMed ID: 11231638
[TBL] [Abstract][Full Text] [Related]
16. Pathogenic IgG4 subclass autoantibodies in MuSK myasthenia gravis.
Plomp JJ; Huijbers MG; van der Maarel SM; Verschuuren JJ
Ann N Y Acad Sci; 2012 Dec; 1275():114-22. PubMed ID: 23278586
[TBL] [Abstract][Full Text] [Related]
17. [Titer of anti-muscle-specific receptor tyrosine kinase (MuSK) antibody correlated with symptomatic improvement in response to corticosteroid therapy in a patient with anti-MuSK antibody-positive myasthenia gravis: a case report].
Nakahama Y; Kawajiri M; Ochi M; Kohara K; Ohta K; Miki T
Rinsho Shinkeigaku; 2007 Jun; 47(6):356-8. PubMed ID: 17633110
[TBL] [Abstract][Full Text] [Related]
18. [Autoantibodies in myasthenia gravis].
Motomura M; Narita Masuda T
Brain Nerve; 2013 Apr; 65(4):433-9. PubMed ID: 23568991
[TBL] [Abstract][Full Text] [Related]
19. Anti-agrin autoantibodies in myasthenia gravis.
Gasperi C; Melms A; Schoser B; Zhang Y; Meltoranta J; Risson V; Schaeffer L; Schalke B; Kröger S
Neurology; 2014 Jun; 82(22):1976-83. PubMed ID: 24793185
[TBL] [Abstract][Full Text] [Related]
20. [Anti-muscle-specific tyrosine kinase (MuSK) antibody].
Ohta M; Ohta K; Shigemoto K; Shimoda Y
Nihon Rinsho; 2010 Jun; 68 Suppl 6():633-6. PubMed ID: 20942150
[No Abstract] [Full Text] [Related]
[Next] [New Search]